This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid013A |
1. Strategies to Optimize ICU Liberation (A to F) Bundle Performance in Critically Ill Adults With Coronavirus Disease 2019. | *32696002* 32696002 | ||
2. Proposal for Coronavirus Disease 2019 Management. | *32671351* 32671351 | ||
3. Haematological and immunological data of Chinese children infected with coronavirus disease 2019. | *32685628* 32685628 | ||
4. Scoring systems for predicting mortality for severe patients with COVID-19. | *C7332889* C7332889 | ||
5. COVID-19 in 7780 pediatric patients: A systematic review. | *C7318942* C7318942 | ||
6. Severity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak: Preliminary data on the role of Helmet CPAP and Non-Invasive Positive Pressure Ventilation. | *C7301102* C7301102 | ||
7. A Predictive Nomogram for Predicting Improved Clinical Outcome Probability in Patients with COVID-19 in Zhejiang Province China. | *C7274972* C7274972 | ||
8. Ventilating two patients with one ventilator: technical setup and laboratory testing. | *32665947* 32665947 | ||
9. COVID-19: (mis)managing an announced Black Swan. | *C7239190* C7239190 | ||
10. The Story behind COVID-19: Animal Diseases at the Crossroads of Wildlife Livestock and Human Health. | *C7248588* C7248588 | ||
11. Pathophysiology and therapy of systemic vasculitides. | *32665772* 32665772 | ||
12. A machine learning model to identify early stage symptoms of SARS-Cov-2 infected patients. | *C7305929* C7305929 | ||
13. Randomized Controlled Study Evaluating Efficiency of Low Intensity Transcranial Direct Current Stimulation (tDCS) for Dyspnea Relief in Mechanically Ventilated COVID-19 Patients in ICU: The tDCS-DYSP-COVID Protocol. | *32671084* 32671084 | ||
14. Pharmacotherapics Advice in Guidelines for COVID-19. | *32670066* 32670066 | ||
15. The Contribution of Surface Tension-Dependent Alveolar Septal Stress Concentrations to Ventilation-Induced Lung Injury in the Acute Respiratory Distress Syndrome. | *32670073* 32670073 | ||
16. Pandemic COVID-19: current status and challenges of antiviral therapies. | *C7340039* C7340039 | ||
17. Development of a vulnerability index for diagnosis with the novel coronavirus COVID-19 in Washington State USA. | *C7318982* C7318982 | ||
18. Precautions for weaning from invasive mechanical ventilation with critically ill COVID-19. | *C7346788* C7346788 | ||
19. ASI’s Consensus Guidelines: ABCs of What to Do and What Not During the COVID-19 Pandemic. | *C7280171* C7280171 | ||
20. Data analytics for novel coronavirus disease. | *C7295495* C7295495 | ||
21. The novel coronavirus 2019-nCoV: Its evolution and transmission into humans causing global COVID-19 pandemic. | *C7247958* C7247958 | ||
22. Considerations for development and use of AI in response to COVID-19. | *C7280134* C7280134 | ||
23. Impact of Digital Surge during Covid-19 Pandemic: A Viewpoint on Research and Practice. | *C7280123* C7280123 | ||
24. Artificial intelligence and COVID-19: A multidisciplinary approach. | *C7255319* C7255319 | ||
25. Reducing aerosol dispersion by High Flow Therapy in COVID‐19: High Resolution Computational Fluid Dynamics Simulations of Particle Behavior during High Velocity Nasal Insufflation with a Simple Surgical Mask. | *C7283709* C7283709 | ||
26. Aerosol Risk with Noninvasive Respiratory Support in Patients with COVID‐19. | *C7280651* C7280651 | ||
27. Dissociation of arterial oxygen saturation and oxygen delivery in VV-ECMO: the trend is your friend. | *C7332908* C7332908 | ||
28. Novel Closed-Loop Bronchoscopy Barrier Sheath: Valuable Addition for One-Lung Ventilation During the Coronavirus Disease 2019 Pandemic. | *32690235* 32690235 | ||
29. COVID-19: A Risk Assessment Perspective. | *C7216769* C7216769 | ||
30. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection. | *32661797* 32661797 | ||
31. Limiting positive end-expiratory pressure to protect renal function in SARS-CoV-2 critically ill patients. | *32683213* 32683213 | ||
32. Novel coronavirus: A capsule review for primary care and acute care physicians. | *32670925* 32670925 | ||
33. COVID-19 – An avoidable epidemic: A family medicine practitioner s perspective. | *32670981* 32670981 | ||
34. The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention. | *32671115* 32671115 | ||
35. Comparing Chinese children and adults with RT-PCR positive COVID-19: A systematic review. | *32682658* 32682658 | ||
36. Prone Position of Patients with COVID-19 and Acute Respiratory Distress Syndrome. | *C7260515* C7260515 | ||
37. Guidance for the Treatment and Management of COVID‐19 Among People with Intellectual Disabilities. | *C7307021* C7307021 | ||
38. COVID19: Challenging tissue viability in both patients and clinicians. | *C7308781* C7308781 | ||
39. Risk-stratifying COVID-19 Patients the Right Way. | *C7250774* C7250774 | ||
40. Cardiac Dysfunction and Shock in Pediatric Patients With COVID-19. | *C7301074* C7301074 | ||
41. COVID-19: My Perspective. | *C7293521* C7293521 | ||
42. Machine learning for COVID-19—asking the right questions. | *C7351424* C7351424 | ||
43. Digital tools against COVID-19: taxonomy ethical challenges and navigation aid. | *C7324107* C7324107 | ||
44. COVID-19 in children and young people. | *C7324116* C7324116 | ||
45. Nano-enabled biosensing systems for intelligent healthcare: towards COVID-19 management. | *C7274574* C7274574 | ||
46. Resilient and agile engineering solutions to address societal challenges such as coronavirus pandemic. | *C7254035* C7254035 | ||
47. Review on machine and deep learning models for the detection and prediction of Coronavirus. | *C7309744* C7309744 | ||
48. Catalysis-in-a-Box: Robotic Screening of Catalytic Materials in the Time of COVID-19 and Beyond. | *C7351032* C7351032 | ||
49. Mayo Clinic Strategies for COVID-19 Analytics and Prediction Modeling During the COVID-19 Pandemic. | *C7306725* C7306725 | ||
50. Innovation Lessons From the COVID-19 Pandemic. | *C7275154* C7275154 | ||
51. MADVent: A low‐cost ventilator for patients with COVID‐19. | *C7300530* C7300530 | ||
52. When success means focusing on the oxygen delivery. A case of conventional management of severe hypoxemia in SARS-CoV-2. | *32690325* 32690325 | ||
53. Children in Coronaviruses’ Wonderland: What Clinicians Need to Know. | *32670520* 32670520 | ||
54. COVID-19 and respiratory support devices. | *32690356* 32690356 | ||
55. COVID-19 – What does a paediatrician need to know? | *C7212951* C7212951 | ||
56. COVID- 19 un Syndrome de Détresse Respiratoire Aigu atypique. | *C7351392* C7351392 | ||
57. Rethinking COVID-19 in children: Lessons learned from pediatric viral and inflammatory cardiovascular diseases. | *C7243773* C7243773 | ||
58. Neurocovid: Pharmacological recommendations for delirium associated with COVID-19. | *C7240270* C7240270 | ||
59. How Might AI and Chest Imaging Help Unravel COVID-19’s Mysteries? | *C7233385* C7233385 | ||
60. Human Coronavirus Infections—Severe Acute Respiratory Syndrome (SARS) Middle East Respiratory Syndrome (MERS) and SARS-CoV-2. | *C7241405* C7241405 | ||
61. Epidemiologic Clinical and Laboratory Findings of the COVID-19 in the current pandemic. | *32702720* 32702720 | ||
62. Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases. | *32707480* 32707480 | ||
63. Necrotizing tracheobronchitis with endotracheal tube obstruction in COVID-19 patients☆. | *C7293480* C7293480 | ||
64. Fisioterapia respiratoria con cinturones de vibración en el paciente crítico Covid-19 en posición de prono. | *C7346828* C7346828 | ||
65. Oxigenoterapia de alto flujo y posición de prono con respiración espontánea en neumonía por SARS-CoV-2. | *C7303598* C7303598 | ||
66. Présentation atypique du Covid-19 chez le jeune enfant. | *C7328544* C7328544 | ||
67. COVID-19: Clinical aspects and therapeutics responses. | *C7332461* C7332461 | ||
68. National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 – a prospective cohort study. | *32660623* 32660623 | ||
69. CPAP Added to Oxygen Administration Avoid Intubation in Acute Respiratory Distress in COVID-19 Pneumonia. Case Report. | *C7301626* C7301626 | ||
70. Compartmental Models of the COVID-19 Pandemic for Physicians and Physician-Scientists. | *C7270519* C7270519 | ||
71. Growth detection quantification and inactivation of SARS-CoV-2. | *C7293183* C7293183 | ||
72. Empfehlungen für ECMO bei COVID-19-Patienten: Consensus Paper zur Extrakorporalen Membranoxygenierung der Medizinischen Universität Wien. | *C7286215* C7286215 | ||
73. COVID-19 from mysterious enemy to an environmental detection process: a critical review. | *C7352094* C7352094 | ||
74. A review of mathematical modeling artificial intelligence and datasets used in the study prediction and management of COVID-19. | *C7335662* C7335662 | ||
75. The effects of personal protective equipment on airway management: An in-situ simulation. | *C7335411* C7335411 | ||
76. Antivirals/direct oral anticoagulants interaction: Anticoagulation drug level increased and off label use: 12 case reports. | *C7334126* C7334126 | ||
77. The COVID-19 pandemic: biological evolution treatment options and consequences. | *C7330532* C7330532 | ||
78. Minireview of progress in the structural study of SARS-CoV-2 proteins. | *C7323663* C7323663 | ||
79. On COVID-19 Modelling. | *C7322402* C7322402 | ||
80. Predictive Data Mining Models for Novel Coronavirus (COVID-19) Infected Patients’ Recovery. | *C7306186* C7306186 | ||
81. Affordable Compact and Infection-Free BiPAP Machine. | *C7305860* C7305860 | ||
82. Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection☆☆☆. | *C7304399* C7304399 | ||
83. Is the prone position indicated in critically ill patients with SARS-CoV-2 during the peri-operative period? | *C7299854* C7299854 | ||
84. COVID-19 with pulmonary involvement. An autoimmune disease of known causeâ. | *C7298508* C7298508 | ||
85. Mechanical Ventilator Using Motorized Bellow. | *C7286705* C7286705 | ||
86. Forecasting Models for Coronavirus Disease (COVID-19): A Survey of the State-of-the-Art. | *C7289234* C7289234 | ||
87. COVID‐19: a brief history and treatments in development. | *C7280658* C7280658 | ||
88. COVID-19: Beyond Respiratory Tract. | *C7295269* C7295269 | ||
89. The SARS-CoV-2 a new pandemic zoonosis that threatens the world☆. | *C7205683* C7205683 | ||
90. Discussion on Etiology and Pathogenesis of Corona Virus Disease 2019 from “Cold-dampness and Insidious Dryness”. | *C7181969* C7181969 | ||
91. Novel use of home pulse oximetry monitoring in COVID‐19 patients discharged from the emergency department identifies need for hospitalization. | *C7323027* C7323027 | ||
92. Where are we with understanding of COVID-19? | *C7305492* C7305492 | ||
93. Recommendations for the prevention and treatment of the novel coronavirus pneumonia in the elderly in China. | *C7300900* C7300900 | ||
94. Diagnosis and treatment strategy of coronavirus disease 2019 with cardiovascular disease in elderly patients. | *C7273077* C7273077 | ||
95. SARS-CoV2 coronavirus: So far polite with children. Debatable immunological and non-immunological evidence. | *C7332921* C7332921 | ||
96. Consistency and reliability of COVID-19 projection models as a means to save lives. | *C7354274* C7354274 | ||
97. Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease. | *C7354270* C7354270 | ||
98. A novel inline PEEP valve design for differential multi-ventilation. | *C7351030* C7351030 | ||
99. Propofol in COVID 19 — From basic science to clinical impact. | *C7347356* C7347356 | ||
100. The authors response: Propofol in COVID 19: From basic science to clinical impact☆. | *32690223* 32690223 | ||
101. Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS. | *C7335247* C7335247 | ||
102. Bayes theorem COVID19 and screening tests. | *C7315940* C7315940 | ||
103. Propofol and sedation in patients with coronavirus disease. | *C7299857* C7299857 | ||
104. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. | *32659413* 32659413 | ||
105. Guidance for evaluating and testing patients for COVID‐19. | *C7267457* C7267457 | ||
106. No added value of the modified NEWS score to predict clinical deterioration in COVID-19 patients. | *32659455* 32659455 | ||
107. Airway Management in COVID-19: In the Den of the Beast. | *C7179066* C7179066 | ||
108. An Interim Solution to the Decreased Availability of Respirators Against COVID-19. | *C7179060* C7179060 | ||
109. Reinventing the Wheel in ARDS: Awake Proning in COVID-19. | *C7332953* C7332953 | ||
110. Mechanical Risks of Ventilator Sharing in the COVID-19 Era: A Simulation-Based Study. | *32682580* 32682580 | ||
111. An Introduction to COVID-19. | *C7307707* C7307707 | ||
112. COVID-19 Update. | *C7273864* C7273864 | ||
113. The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis. | *32639742* 32639742 | ||
114. Machine learning to assist clinical decision-making during the COVID-19 pandemic. | *C7347420* C7347420 | ||
115. COVID-19: How to Use a Jet Nebulizer for Drug Administration in Ventilated Patients without Putting the Healthcare Workers at Risk. | *C7316646* C7316646 | ||
116. Comprehensive review of coronavirus disease 2019 (COVID-19). | *C7263230* C7263230 | ||
117. Natural history of COVID-19 and current knowledge on treatment therapeutic options. | *C7332915* C7332915 | ||
118. Inhaler with electrostatic sterilizer and use of cationic amphiphilic peptides may accelerate recovery from COVID-19. | *C7299243* C7299243 | ||
119. Interdependence between elevated intra-abdominal pleural and airway opening pressure in severe acute respiratory distress syndrome with extracorporeal membrane oxygenation. | *32682550* 32682550 | ||
120. Airway management lessons from case reports of negative outcomes. Comment on Br J Anaesth; 125: e168–70. | *32680606* 32680606 | ||
121. Regulating inspiratory pressure to individualise tidal volumes in a simulated two-patient one-ventilator system. | *C7324329* C7324329 | ||
122. COVID-19: a complex multisystem disorder. | *C7305919* C7305919 | ||
123. What unusual symptoms to seek for COVID-19? | *C7357972* C7357972 | ||
124. Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019-associated Acute Respiratory Distress Syndrome: An Initial US Experience at a High-volume Centre. | *32670617* 32670617 | ||
125. Emerging Technologies for Use in the Study Diagnosis and Treatment of Patients with COVID-19. | *C7314428* C7314428 | ||
126. Applications of machine learning and artificial intelligence for Covid-19 (SARS-CoV-2) pandemic: A review. | *C7315944* C7315944 | ||
127. Role of Intelligent Computing in COVID-19 Prognosis: A State-of-the-Art Review. | *C7256553* C7256553 | ||
128. Current strategies against COVID-19. | *C7344049* C7344049 | ||
129. COVID-19: Review and hematologic impact. | *32659224* 32659224 | ||
130. From encephalitis lethargica to COVID-19: Is there another epidemic ahead? | *32659638* 32659638 | ||
131. Hypofractionated Accelerated Concurrent Chemoradiotherapy in Inoperable Stage III Non-small Cell Lung Cancer: SOCCAR. A Large Single-Centre Experience. | *32665103* 32665103 | ||
132. Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome. | *32665007* 32665007 | ||
133. Percutaneous Tracheostomy With Apnea During Coronavirus Disease 2019 Era: A Protocol and Brief Report of Cases. | *32671354* 32671354 | ||
73. COVID-19 from mysterious enemy to an environmental detection process: a critical review. | *C7352094* C7352094 | ||
74. A review of mathematical modeling artificial intelligence and datasets used in the study prediction and management of COVID-19. | *C7335662* C7335662 | ||
75. The effects of personal protective equipment on airway management: An in-situ simulation. | *C7335411* C7335411 | ||
76. Antivirals/direct oral anticoagulants interaction: Anticoagulation drug level increased and off label use: 12 case reports. | *C7334126* C7334126 | ||
77. The COVID-19 pandemic: biological evolution treatment options and consequences. | *C7330532* C7330532 | ||
78. Minireview of progress in the structural study of SARS-CoV-2 proteins. | *C7323663* C7323663 | ||
79. On COVID-19 Modelling. | *C7322402* C7322402 | ||
80. Predictive Data Mining Models for Novel Coronavirus (COVID-19) Infected Patients’ Recovery. | *C7306186* C7306186 | ||
81. Affordable Compact and Infection-Free BiPAP Machine. | *C7305860* C7305860 | ||
82. Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection☆☆☆. | *C7304399* C7304399 | ||
83. Is the prone position indicated in critically ill patients with SARS-CoV-2 during the peri-operative period? | *C7299854* C7299854 | ||
84. COVID-19 with pulmonary involvement. An autoimmune disease of known causeâ. | *C7298508* C7298508 | ||
85. Mechanical Ventilator Using Motorized Bellow. | *C7286705* C7286705 | ||
86. Forecasting Models for Coronavirus Disease (COVID-19): A Survey of the State-of-the-Art. | *C7289234* C7289234 | ||
87. COVID‐19: a brief history and treatments in development. | *C7280658* C7280658 | ||
88. COVID-19: Beyond Respiratory Tract. | *C7295269* C7295269 | ||
89. The SARS-CoV-2 a new pandemic zoonosis that threatens the world☆. | *C7205683* C7205683 | ||
90. Discussion on Etiology and Pathogenesis of Corona Virus Disease 2019 from “Cold-dampness and Insidious Dryness”. | *C7181969* C7181969 | ||
91. Novel use of home pulse oximetry monitoring in COVID‐19 patients discharged from the emergency department identifies need for hospitalization. | *C7323027* C7323027 | ||
92. Where are we with understanding of COVID-19? | *C7305492* C7305492 | ||
93. Recommendations for the prevention and treatment of the novel coronavirus pneumonia in the elderly in China. | *C7300900* C7300900 | ||
94. Diagnosis and treatment strategy of coronavirus disease 2019 with cardiovascular disease in elderly patients. | *C7273077* C7273077 | ||
95. SARS-CoV2 coronavirus: So far polite with children. Debatable immunological and non-immunological evidence. | *C7332921* C7332921 | ||
96. Consistency and reliability of COVID-19 projection models as a means to save lives. | *C7354274* C7354274 | ||
97. Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease. | *C7354270* C7354270 | ||
98. A novel inline PEEP valve design for differential multi-ventilation. | *C7351030* C7351030 | ||
99. Propofol in COVID 19 — From basic science to clinical impact. | *C7347356* C7347356 | ||
100. The authors response: Propofol in COVID 19: From basic science to clinical impact☆. | *32690223* 32690223 | ||
101. Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS. | *C7335247* C7335247 | ||
102. Bayes theorem COVID19 and screening tests. | *C7315940* C7315940 | ||
103. Propofol and sedation in patients with coronavirus disease. | *C7299857* C7299857 | ||
104. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. | *32659413* 32659413 | ||
105. Guidance for evaluating and testing patients for COVID‐19. | *C7267457* C7267457 | ||
106. No added value of the modified NEWS score to predict clinical deterioration in COVID-19 patients. | *32659455* 32659455 | ||
107. Airway Management in COVID-19: In the Den of the Beast. | *C7179066* C7179066 | ||
108. An Interim Solution to the Decreased Availability of Respirators Against COVID-19. | *C7179060* C7179060 | ||
109. Reinventing the Wheel in ARDS: Awake Proning in COVID-19. | *C7332953* C7332953 | ||
110. Mechanical Risks of Ventilator Sharing in the COVID-19 Era: A Simulation-Based Study. | *32682580* 32682580 | ||
111. An Introduction to COVID-19. | *C7307707* C7307707 | ||
112. COVID-19 Update. | *C7273864* C7273864 | ||
113. The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis. | *32639742* 32639742 | ||
114. Machine learning to assist clinical decision-making during the COVID-19 pandemic. | *C7347420* C7347420 | ||
115. COVID-19: How to Use a Jet Nebulizer for Drug Administration in Ventilated Patients without Putting the Healthcare Workers at Risk. | *C7316646* C7316646 | ||
116. Comprehensive review of coronavirus disease 2019 (COVID-19). | *C7263230* C7263230 | ||
117. Natural history of COVID-19 and current knowledge on treatment therapeutic options. | *C7332915* C7332915 | ||
118. Inhaler with electrostatic sterilizer and use of cationic amphiphilic peptides may accelerate recovery from COVID-19. | *C7299243* C7299243 | ||
119. Interdependence between elevated intra-abdominal pleural and airway opening pressure in severe acute respiratory distress syndrome with extracorporeal membrane oxygenation. | *32682550* 32682550 | ||
120. Airway management lessons from case reports of negative outcomes. Comment on Br J Anaesth; 125: e168–70. | *32680606* 32680606 | ||
121. Regulating inspiratory pressure to individualise tidal volumes in a simulated two-patient one-ventilator system. | *C7324329* C7324329 | ||
122. COVID-19: a complex multisystem disorder. | *C7305919* C7305919 | ||
123. What unusual symptoms to seek for COVID-19? | *C7357972* C7357972 | ||
124. Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019-associated Acute Respiratory Distress Syndrome: An Initial US Experience at a High-volume Centre. | *32670617* 32670617 | ||
125. Emerging Technologies for Use in the Study Diagnosis and Treatment of Patients with COVID-19. | *C7314428* C7314428 | ||
126. Applications of machine learning and artificial intelligence for Covid-19 (SARS-CoV-2) pandemic: A review. | *C7315944* C7315944 | ||
127. Role of Intelligent Computing in COVID-19 Prognosis: A State-of-the-Art Review. | *C7256553* C7256553 | ||
128. Current strategies against COVID-19. | *C7344049* C7344049 | ||
129. COVID-19: Review and hematologic impact. | *32659224* 32659224 | ||
130. From encephalitis lethargica to COVID-19: Is there another epidemic ahead? | *32659638* 32659638 | ||
131. Hypofractionated Accelerated Concurrent Chemoradiotherapy in Inoperable Stage III Non-small Cell Lung Cancer: SOCCAR. A Large Single-Centre Experience. | *32665103* 32665103 | ||
132. Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome. | *32665007* 32665007 | ||
133. Percutaneous Tracheostomy With Apnea During Coronavirus Disease 2019 Era: A Protocol and Brief Report of Cases. | *32671354* 32671354 | ||
PMC7327402 1. Clinical Characteristics of Children with COVID-19. | *32617354* 32617354 | ||
PMC7299850 2. The authors' response: Propofol and sedation in patients with coronavirus disease 2019. | *32611498* 32611498 | ||
PMC7237499 3. Glycemic control of type 2 diabetic patients with coronavirus disease during hospitalization: a proposal for early insulin therapy. | *32401039* 32401039 | ||
PMC7287458 4. Insuficiencia respiratoria COVID-19: soporte con ECMO para ninos y adultos jovenes. | *32616399* 32616399 | ||
PMC7313489 5. Implementation of a non-invasive oxygenation support strategy during the COVID-19 pandemic in an ephemeral Respiratory Intermediate Care Unit. | *32651097* 32651097 | ||
PMC7198210 6. Ventilating multiple patients on a single ventilator: Statement from the French Society of Anaesthesia and Intensive Care (SFAR). | *32418868* 32418868 | ||
PMC7268869 7. Shared Ventilation: Toward Safer Ventilator Splitting in Resource Emergencies. | *32467451* 32467451 | ||
PMC7223577 8. Remote Control and Monitoring of GE Aisys Anesthesia Machines Repurposed as Intensive Care Unit Ventilators. | *32358251* 32358251 | ||
PMC7347472 9. Permissive apnea in CoVid 19 Tracheostomy: alternative healthworkers safe procedure in Intensive Care Unit. | *32653361* 32653361 | ||
PMC7333156 10. Hemodynamic monitoring in patients with venoarterial extracorporeal membrane oxygenation. | *32647717* 32647717 | ||
PMC7327324 11. COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon. | *32617313* 32617313 | ||
PMC7233243 12. Viral G-quadruplexes: New frontiers in virus pathogenesis and antiviral therapy. | *32427223* 32427223 | ||
PMC7293452 13. Handling children in COVID wards: A narrative experience and suggestions for providing psychological support. | *32599438* 32599438 | ||
PMC7130245 14. Preliminary Findings on Control of Dispersion of Aerosols and Droplets During High-Velocity Nasal Insufflation Therapy Using a Simple Surgical Mask: Implications for the High-Flow Nasal Cannula. | *32247712* 32247712 | ||
PMC7213636 15. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). | *32358325* 32358325 | ||
PMC7213628 16. Extracorporeal membrane oxygenation support in 2019 novel coronavirus disease: indications, timing, and implementation. | *32118643* 32118643 | ||
PMC7289291 17. Interpretations of "Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)". | *32301757* 32301757 | ||
PMC7289304 18. Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment. | *32209887* 32209887 | ||
PMC7108176 19. Origin and Evolution of the 2019 Novel Coronavirus. | *32011673* 32011673 | ||
PMC7300635 20. Improved mechanical ventilation requires more than just increased ventilator availability: A word of caution. | *32508025* 32508025 | ||
PMC7224349 21. Safe doubling of ventilator capacity: a last resort proposal for last resorts. | *32410701* 32410701 | ||
PMC7311184 22. Mobilization practices in critically ill children: a European point prevalence study (EU PARK-PICU). | *32576273* 32576273 | ||
PMC7188417 23. Using the Surviving Sepsis Coronavirus Disease 2019 Guidelines-Anything New Yet? | *32426741* 32426741 | ||
PMC7328442 24. Extracorporeal Membrane Oxygenation During the Coronavirus Disease 2019 Pandemic. | *32618698* 32618698 | ||
PMC7314324 25. Adult Extracorporeal Membrane Oxygenation Patient Selection During Coronavirus Disease 2019: The Value of a Review Panel During Coronavirus Disease 2019. | *32541567* 32541567 | ||
PMC7343316 26. Clinical Perspective on 2019 Novel Coronavirus Pneumonia: A Systematic Review of Published Case Reports. | *32656006* 32656006 | ||
PMC7260568 27. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. | *32623267* 32623267 | ||
PMC7235856 28. Artificial Intelligence in Radiology-Ethical Considerations. | *32316503* 32316503 | ||
PMC7095077 29. Coronavirus outbreaks: prevention and management recommendations. | *32218651* 32218651 | ||
PMC7207156 30. 10 Questions and 4 experts on Corona: Answers by Akiko Iwasaki, Gerard Krause, Samuel Alizon, and Rino Rappuoli. | *32246897* 32246897 | ||
PMC7241107 31. Will children reveal their secret? The coronavirus dilemma. | *32430424* 32430424 | ||
PMC7236833 32. Will children reveal their secret? The coronavirus dilemma. | *32398300* 32398300 | ||
PMC7241108 33. A predictive model for disease progression in non-severely ill patients with coronavirus disease 2019. | *32430433* 32430433 | ||
PMC7311136 34. Unclear Issues Regarding COVID-19. | *32612430* 32612430 | ||
PMC7292148 35. A Novel Scoring System for Prediction of Disease Severity in COVID-19. | *32582575* 32582575 | ||
PMC7308593 36. Immune Response, Inflammation, and the Clinical Spectrum of COVID-19. | *32612615* 32612615 | ||
PMC7324777 37. Children Infected With SARS-CoV-2 From Family Clusters. | *32656172* 32656172 | ||
PMC7314948 38. The COVID-19 Diagnostic Technology Landscape: Efficient Data Sharing Drives Diagnostic Development. | *32626682* 32626682 | ||
PMC7308592 39. Clinical Features of 33 Cases in Children Infected With SARS-CoV-2 in Anhui Province, China-A Multi-Center Retrospective Cohort Study. | *32612971* 32612971 | ||
PMC7296579 40. Technological developments driven by COVID. | *32550291* 32550291 | ||
PMC7331859 41. Coronavirus Disease 2019: A Gastroenterologist's Perspective in May 2020. | *32655724* 32655724 | ||
PMC7286227 42. Covid-19 treatment-induced neuropsychiatric adverse effects. | *32636036* 32636036 | ||
PMC7148597 43. Interpretation of the diagnosis and treatment plan of Corona Virus Disease 2019 (tentative fifth revised edition). | *32292829* 32292829 | ||
PMC7241413 44. The application of DNA nucleotide footprint plotting in coronavirus. | *32542185* 32542185 | ||
PMC7265848 45. Remote ischemic preconditioning: Lung protection in the time of a pandemic? | *32502776* 32502776 | ||
PMC7291979 46. Pandemics and methodological developments in epidemiology history. | *32540385* 32540385 | ||
PMC7341040 47. Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: Systematic review using a discounting approach. | *32652215* 32652215 | ||
PMC7228410 48. A survey of 434 clinical trials about coronavirus disease 2019 in China. | *32220077* 32220077 | ||
PMC7269276 49. Coronavirus disease-2019: A brief compilation of facts. | *32508437* 32508437 | ||
PMC7228312 50. Three children who recovered from novel coronavirus 2019 pneumonia. | *32202014* 32202014 | ||
PMC7351538 51. Guidance for Healthcare Providers Managing COVID-19 in Rural and Underserved Areas. | *32651882* 32651882 | ||
PMC7129103 52. Coronaviruses: Facts, Myths, and Hypotheses. | *32151778* 32151778 | ||
PMC7297072 53. Mitigating Pressure Injury Challenges When Placing Patients in a Prone Position: A View From Here. | *32487914* 32487914 | ||
PMC7347350 54. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. | *32653054* 32653054 | ||
PMC7228374 55. MASS SPECTROMETRY IN VIROLOGICAL SCIENCES. | *31876329* 31876329 | ||
PMC7211698 56. Sharing a single ventilator ("In vitro"). | *32493646* 32493646 | ||
PMC7351543 57. CRISPRing for host genes regulating SARS-CoV-2. | *32651570* 32651570 | ||
PMC7130868 58. Chinese illness caused by a virus. | *32287783* 32287783 | ||
PMC7284672 59. SARS-CoV-2 Infektion bei Kindern und Jugendlichen: Ein Literaturuberblick der AG Infektiologie der OGKJ1. | *32536725* 32536725 | ||
PMC7340132 60. Coronavirus Disease 2019: Understanding Immunopathogenesis Is the "Holy Grail" to Explain Why Children Have Less Severe Acute Disease. | *32618678* 32618678 | ||
PMC7264765 61. Why is Coronavirus Disease 2019 not as severe in children?-A look at type 2 alveolar cells. | *32314538* 32314538 | ||
PMC7300687 62. Pediatric coronavirus disease-2019: How to assess chest disease? | *32511881* 32511881 | ||
PMC7332738 63. Management strategies for children with COVID-19: ESPR practical recommendations. | *32621013* 32621013 | ||
PMC7331623 64. Hemogram data as a tool for decision-making in COVID-19 management: applications to resource scarcity scenarios. | *32656001* 32656001 | ||
PMC7321050 65. Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020. | *32653383* 32653383 | ||
PMC7235473 66. The 2019 human coronavirus: Ten areas of uncertainty waiting to be resolved. | *32394505* 32394505 | ||
PMC7334563 67. COVID-19 in Children: An Ample Review. | *32636686* 32636686 | ||
PMC7259824 68. A rapidly deployable individualized system for augmenting ventilator capacity. | *32424018* 32424018 | ||
PMC7351651 69. COVID-19: clinical issues from the Japan Surgical Society. | *32651686* 32651686 | ||
70. Time Course of Evolving Ventilator-Induced Lung Injury: The "Shrinking Baby Lung". | *32392018* 32392018 | ||